Yes fair concerns, from the interview that @Sharing990 provided the link to, JK is clearly aware of these issues.
As I posted the other day:
So the NG Biotech test is available for use in Europe.
Number of cases in Europe = 1,168,284 at time of posting now 1,300,838
Number of people in Europe = 741,000,000
Seems like a good opportunity for sales in Europe alone.
- Forums
- ASX - By Stock
- Potential SP Valuation of AT1 - 80 cents to 1.30/share
Yes fair concerns, from the interview that @Sharing990 provided...
-
- There are more pages in this discussion • 1,326 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.98M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 141081 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.025 |
3 | 164617 | 0.024 |
4 | 850391 | 0.023 |
6 | 725023 | 0.022 |
3 | 194292 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 141081 | 1 |
0.027 | 5550 | 1 |
0.028 | 55890 | 2 |
0.029 | 425248 | 5 |
0.030 | 517288 | 9 |
Last trade - 08.34am 26/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
Day chart unavailable